Lotus Lake Ventures

iRegene is a biotechnology company that specializes in researching and developing pharmaceutical therapies for neurodegenerative and rare diseases. The company is at the forefront of innovating chemically defined cell therapies, utilizing a chemical induction system to generate human cell types with high purity. This advanced approach aims to create effective treatments for conditions such as Parkinson's disease and various forms of blindness. By focusing on these challenging medical conditions, iRegene aspires to enhance treatment options available to healthcare professionals, ultimately improving patient outcomes.

Juzheng Medical develops medical device products, specializing in the study, creation, and manufacturing of medical devices. It is committed to providing innovative medical devices for vascular interventional treatments.

Qingwei Rufeng Technology is an autonomous vehicle company that offers solutions for unmanned and digitalized airport logistics transportation.

Reprogenix is a pioneering medical technology company specializing in regenerative stem cell medicine. It initially focused on stem cell therapy for diabetes and has since expanded its scope to develop advanced biomedical solutions for various disease areas. The company leverages proprietary human pluripotent stem cell technology to create innovative, regenerative treatments.

Huiyue Medical focuses on the development, production and sales of artificial intelligence surgical robots.

Better MedTech is a company dedicated to advancing urinary and pelvic floor health through the research, development, and production of specialized medical devices. It focuses on creating innovative solutions for conditions such as benign prostatic hyperplasia, urinary incontinence, urinary stones, and novel tumor therapies. By combining cutting-edge technology with comprehensive medical expertise, Better MedTech aims to deliver precise and effective products that enhance patient care and improve outcomes in these critical areas of health.

Juzheng Medical develops medical device products, specializing in the study, creation, and manufacturing of medical devices. It is committed to providing innovative medical devices for vascular interventional treatments.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies, specifically targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in the biotechnology sector. By providing antibody-based drugs that enhance immune system functionality, along with technical consultation and drug quality inspection services, Kanova enables its clients to improve drug quality and efficiently advance the field of biomedicine.

Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.

SinoTau is a comprehensive solution provider in the pharmaceutical sector, focusing on both generic and innovative drugs. The company specializes in the early development of antibody biopharmaceuticals and produces advanced generic medications. It aims to address various therapeutic areas, including cardiovascular diseases, neurodegeneration, and tumors. SinoTau's expertise encompasses medicinal chemical synthesis, generic drug analysis, pharmaceutical preparations, and drug registration, supported by leading research in targeted drug development. The company leverages advanced diagnostic methods and monoclonal antibody technologies to enhance its offerings, positioning itself as a key player in the biotechnology industry.

VDJ is an antibody affinity enhancement platform that simulates the maturation mechanism of human antibodies and is specialized in autoimmune diseases. Their products include IL-6R antibodies and CTLA-4-Ig. They serve markets.

Sijian Bio is a progressive antibody research and development firm.

Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.

Cygnus Biosciences (Beijing) Co., Ltd. is a biotechnology firm focused on the research and development of gene sequencing platforms. The company is dedicated to the industrialization of these technologies for clinical medicine screening and diagnosis. By leveraging advanced gene sequencing technology, Cygnus provides accurate and efficient biotech solutions, enabling genetic engineers and gene therapy specialists to obtain reliable data inputs and readings. This capability supports researchers in conducting experiments and deriving conclusions with enhanced effectiveness and minimal error. Through its innovative approach, Cygnus Biosciences aims to advance the field of genetics and improve clinical outcomes.

Care is a medical technology company focused on developing innovative solutions for neurological diseases. The company specializes in researching and creating advanced software, hardware, and artificial intelligence technologies aimed at improving the screening, diagnosis, treatment, and research of various neurological conditions. Through its commitment to innovation, Care seeks to enhance the capabilities of medical practitioners and improve patient outcomes in the field of neurology.

UGa Technology's research and development of GaN RF chips for the next generation of wireless communication equipment They provide solutions for the booming wireless communication industry. They also provide compound semiconductor devices. They can also be adapted to other RF device manufacturers’ products.

Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.

Beijing Huaguan Biotechnology specializes in providing integrated drug research and development services, primarily focusing on small molecules and antibody-drug conjugates (ADCs). The company is recognized for its highly skilled and experienced team, which is equipped with advanced experimental technology to facilitate pre-clinical pharmaceutical research. Huaguan Biotechnology serves a diverse clientele, including prominent domestic pharmaceutical firms like Sihuan Pharmaceutical and Sichuan Kelun, as well as innovative technology enterprises such as Suzhou Amate and Jiangsu Ya Sheng. The company’s reputation for effective team development and service quality has garnered recognition within the industry, attracting investments from listed companies.

ICE Bioscience Inc. is a contract research organization based in Beijing, China, specializing in preclinical research solutions for electrophysiology and drug discovery. Founded in 2010, the company focuses on the development of ion channel-related drugs, particularly targeting the nervous and cardiovascular systems. ICE Bioscience offers a range of services, including ion channel screening, cardiac safety panels, and molecular biology, utilizing proprietary cell lines for voltage-gated and ligand-gated ion channels. The company is also dedicated to expanding its capabilities in immunology, oncology, and other areas, providing comprehensive support for target validation and preclinical candidate identification. Through its advanced screening platforms and flexible collaboration models, ICE Bioscience aims to enhance the efficiency of the drug discovery process for various clinical needs.

China Immunotech is an innovative drug research and development company specializing in immune cell therapy technologies and products. Founded in March 2018 by prominent immunologists, the company is dedicated to the development and commercialization of cellular immunotherapy aimed at treating various diseases. China Immunotech has established two unique technological platforms, STAR-T and TCR-T, which are designed to enable treatment for patients with hematological tumors and to inhibit tumor recurrence. The company holds independent intellectual property rights for its therapies, including CAR-T and TCR-T cell therapies, underscoring its commitment to advancing the field of immunotherapy.

Immupeutics Medical Technology Co., Ltd. is a biomedical research company specializing in tumor immunotherapy. The firm is dedicated to the research and development of immune cell therapy drugs targeting various types of tumors. In addition to its primary focus on therapeutic agents, Immupeutics also invests in companion diagnostic technology and immunological multi-omics technology. By integrating these innovative approaches, the company aims to enhance patient outcomes through the provision of advanced immune cell therapies and comprehensive treatment methodologies.

Neural Galaxy is a brain science company that emerged from Harvard Medical School and the Massachusetts Institute of Technology. The organization focuses on addressing brain disorders through advanced software and hardware technologies. By leveraging breakthrough research in brain science, Neural Galaxy aims to enhance understanding of the brain and high-level intelligence. Its mission includes tackling significant challenges related to brain diseases and improving treatment options, ultimately contributing to a deeper comprehension of human cognition and enhancing overall societal intelligence.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies, specifically targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in the biotechnology sector. By providing antibody-based drugs that enhance immune system functionality, along with technical consultation and drug quality inspection services, Kanova enables its clients to improve drug quality and efficiently advance the field of biomedicine.

Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Slichem is a manufacturer based in Shijiazhuang, China, specializing in the development of liquid crystal materials and fine chemicals. The company focuses on producing display materials, including liquid crystal materials for various applications and OLED materials. Slichem's expertise lies in creating advanced materials that cater to the growing demand in the display technology sector.

Venmedtech produces testing, inspection, and processing equipment. They engaged in the research and development of production and sales of interventional devices related to venous vascular diseases.

Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

SinoTau is a comprehensive solution provider in the pharmaceutical sector, focusing on both generic and innovative drugs. The company specializes in the early development of antibody biopharmaceuticals and produces advanced generic medications. It aims to address various therapeutic areas, including cardiovascular diseases, neurodegeneration, and tumors. SinoTau's expertise encompasses medicinal chemical synthesis, generic drug analysis, pharmaceutical preparations, and drug registration, supported by leading research in targeted drug development. The company leverages advanced diagnostic methods and monoclonal antibody technologies to enhance its offerings, positioning itself as a key player in the biotechnology industry.

Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

OptoMedic is a company focused on the research, development, and production of advanced optical medical devices and systems. It specializes in medical fluorescence navigation endoscopes that leverage aerospace and military optical technology for medical applications. Its product portfolio includes endoscopic monitoring equipment, cancer screening tools, endoscopic navigation systems, and fluorescent imaging systems. These innovations are designed to enhance the ability of medical institutions and healthcare professionals to effectively assess and monitor patient conditions.

Sensylink Microelectronics Co., Ltd. specializes in the design, development, manufacturing, and marketing of environmental sensor integrated circuits (ICs), focusing on temperature, humidity, and gas sensors. The company integrates innovative sensor technology with advanced IC design processes, resulting in products that are compact, energy-efficient, and characterized by high precision and low power consumption. Sensylink aims to provide cost-effective environmental sensor components and services to customers worldwide, with a strong foundation in China. By enabling enterprises to create superior measurement devices, Sensylink contributes to advancements in environmental monitoring and sensor technology.

Beijing Lidakang Technology Co., Ltd., established in 1998, specializes in the manufacturing and distribution of surgical implants. Its product portfolio includes artificial joint systems for hips, knees, and bone tumors, crafted from materials like microporous titanium alloy. These high-quality implants are designed to meet the needs of healthcare professionals and improve patient outcomes.

RealAI is an artificial intelligence technology firm that offers a range of innovative solutions aimed at enhancing operational efficiency across various industries. The company specializes in financial smart risk control and management, as well as advanced face recognition systems. Additionally, RealAI develops technologies for industrial vision inspection, predictive equipment maintenance, and optimization of equipment operation parameters. By providing these services, RealAI helps enterprises improve their overall control and efficiency, addressing critical needs in the evolving technological landscape.

Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices. Specializing in minimally invasive treatments for mitral valve regurgitation, the company’s flagship product is the Valve Clamp, an interventional device designed to assist in the closure of heart valves during surgical procedures. By focusing on innovative solutions for heart valve diseases, Hanyu Medical aims to enhance surgical outcomes and patient recovery through its advanced medical technologies.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies, specifically targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in the biotechnology sector. By providing antibody-based drugs that enhance immune system functionality, along with technical consultation and drug quality inspection services, Kanova enables its clients to improve drug quality and efficiently advance the field of biomedicine.

Chinac.com is a prominent Chinese cloud computing infrastructure operator that specializes in the research, development, and management of commercial cloud computing solutions. The company offers a range of IT services, including cloud storage and computing infrastructure, catering to both domestic and international clients. Chinac.com operates as a provider of Software as a Service (SaaS) and Platform as a Service (PaaS), while also engaging in traditional software development and system integration. The firm supports a diverse array of sectors, including online gaming, e-commerce, mobile internet, online education, and social networking. With tens of thousands of physical server clusters and 20 data centers across more than 15 cities, Chinac.com boasts a robust network that encompasses major telecommunications providers.

Kiwi Green Technologies is a developer of recycling and environmental energy technologies. The company specializes in converting waste into new energy, offering solutions that enable both government and corporate clients to produce green and renewable energy. By focusing on recycling and energy generation, Kiwi Green Technologies aims to significantly lower the costs associated with treating environmental pollutants, thereby promoting sustainable practices and reducing the ecological impact of waste.

IntEngine, operating under the name Tanjing Technology, specializes in the development of storage-first architecture, focusing on end-side AI chips and solutions for Internet of Things (IoT) terminal devices. The company is dedicated to enhancing efficiency in daily life through innovative software algorithms and chip hardware technology. IntEngine emphasizes deep learning and machine learning algorithms, providing tailored neural networks and terminal equipment to assist in security upgrades for monitoring systems. By delivering advanced digitalization solutions, IntEngine aims to serve industrial users effectively, facilitating improvements in operational efficiency and security.

Sinogene is a biotechnology company that specializes in pet cloning using somatic cell nuclear transfer technology. The company's team comprises scientists, doctors, and veterinary specialists who aim to advance animal genetic research through their services. Sinogene focuses on cloning and breeding various types of dogs, including working, pet, and purebred noble breeds, as well as preserving somatic cells' genes for future use in pet cloning and gene editing services.

Cameraking Technology is the distributor of the Internet of Things and applications to achieve image products. They are capable of designing core devices, integrating the supply chains of various industries, and producing and manufacturing goods. They offer manufacturing services as well as prompt, competent support for imaging technology. Their organization is made up of chip companies, solution providers, the internet of things, AI, and subindustry leaders.

Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.

ZIYAN UAV is a research and development company focused on creating small and medium-sized electric unmanned helicopters designed for various applications. These helicopters serve civilian purposes, including power line inspection, public security, mining, mapping, and logistics. They are characterized by high speed, significant maximum takeoff weight, and operational efficiency. ZIYAN UAV integrates advanced technologies such as moving base systems, swarm technology, artificial intelligence modules, and a cloud-based software platform. This comprehensive approach facilitates the development of Internet of Things solutions, enhancing data accessibility and enabling intelligent decision-making for users across multiple sectors, including rescue operations and border patrol.

UWorld is a mobile merchant platform that provides billing services.

Replays is an e-sports comprehensive website mainly provides content such as sports video, industry news, tactical reports, and interviews.

Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.

SolarVista Media Co., Ltd is a Chinese company specializing in outdoor advertising solutions. The firm focuses on delivering innovative digital advertising through DCP billboards that utilize natural light for image display. This technology allows for the electronic alteration of advertisements without generating plastic waste, making it a more environmentally friendly option for marketing campaigns. By offering a sustainable approach to outdoor advertising, SolarVista Media aims to enhance the effectiveness of advertising while minimizing its environmental impact.

Palmap, Inc. is an indoor map service provider based in Shanghai, China, founded in 2010. The company specializes in indoor localization and navigation, offering comprehensive solutions tailored to various sectors such as commercial complexes, tourist destinations, hospitals, exhibitions, transportation centers, and educational institutions. Palmap operates the largest indoor map database in China, featuring over 20,000 indoor maps and 3.5 million points of interest across 350 cities, encompassing 79 different types of buildings. Its mapping technology supports 2D, 2.5D, and 3D formats, allowing for features like rotation, zooming, and navigation. Utilizing advanced positioning technologies through WiFi and Bluetooth Low Energy (BLE), Palmap achieves high-accuracy positioning with a precision of 3-5 meters for WiFi and 1-3 meters for BLE. The company analyzes positioning data to provide insights on passenger flow and behavior, enabling clients to improve operational management, enhance service standards, and optimize marketing strategies.

Baiwan is an interactive entertainment platform. They provide mobile terminal users with quality content such as small games, animations, MTV, web games, and online entertainment. They make web games more colorful, ubiquitous, and fun. They offer smart phone software based on android, symbian and apple systems.

Beijing Hisign Technology Co., Ltd., established in 1998, is a leading enterprise in China's multi-biometrics industry. The company is recognized for its advanced technologies in face recognition, fingerprint identification, palm print matching, handwriting recognition, and vehicle license plate recognition. Hisign is ISO 9001, ISO/IEC 20000-1, and ISO/IEC 27001 certified, reflecting its commitment to quality and security. Its diverse product offerings span multiple sectors, including public security for criminal investigations, forensics, and border control, as well as civil applications in finance, social security, education, transportation, and event management. Hisign's solutions integrate big data analysis for financial risk prevention and control, making it a comprehensive provider of biometric identification technologies in China.

AISpeech is a technology startup focused on enhancing human-machine interaction through advanced voice interaction technology. The company specializes in computer speech recognition, tone analysis, and dialog management techniques. It develops a human-computer dialogue operating system and artificial intelligence chip modules aimed at improving various aspects of voice technology, including speech recognition, speech synthesis, natural language understanding, and voice-print recognition. By offering these innovative solutions, AISpeech enables clients to access intelligent and interactive natural language services, thereby facilitating more effective communication between humans and machines.

Global Gem Exchange is an independent trading platform focused on the jewelry and jade market. It serves as a diamond exchange that facilitates the trading of diamonds and other gems within the global market. The company aims to connect diamond suppliers directly with retailers, streamlining the supply chain and allowing clients to enhance their gem inventory. By providing a marketplace for these transactions, Global Gem Exchange seeks to enable its customers to increase their revenue generation through improved access to high-quality gemstones.

Shenogen Pharma Group is a drug discovery and development company.

Chinese Online (中文在线) is a company focused on digital publishing. It provides digital reading products to mobile phones, hand-held terminals, and the internet as well as other media. Chinese Online takes copyright organizations and authors as the genuine digital content source, and collaborates with them to manage the content. It also offers value-added services of digital content such as copyright derivatives and more. As a leading enterprise of digital publishing domestically, Chinese Online has established a complete media publishing model of unique content, variety in media and synchronized publishing.

Beijing Unifly Scientific and Technology Company Limited specializes in the research, development, manufacturing, and sale of automotive maintenance products, focusing on environmentally-friendly solutions. Founded in 1995 and headquartered in Beijing, China, the company offers a range of products including filters, low-carbon lubricants, glass cleaners, and antifreeze coolants. Its product offerings cater to various industries such as transportation, automobile parts, mining, metallurgy, and power generation. Unifly is committed to energy-saving and environmental protection, providing innovative materials and technologies that help vehicle owners maintain their cars while minimizing ecological impact. The company also has a research and development center located in Langfang, China, further enhancing its capabilities in developing new material technologies and derivative products.

Beijing Unifly Scientific and Technology Company Limited specializes in the research, development, manufacturing, and sale of automotive maintenance products, focusing on environmentally-friendly solutions. Founded in 1995 and headquartered in Beijing, China, the company offers a range of products including filters, low-carbon lubricants, glass cleaners, and antifreeze coolants. Its product offerings cater to various industries such as transportation, automobile parts, mining, metallurgy, and power generation. Unifly is committed to energy-saving and environmental protection, providing innovative materials and technologies that help vehicle owners maintain their cars while minimizing ecological impact. The company also has a research and development center located in Langfang, China, further enhancing its capabilities in developing new material technologies and derivative products.

Achievo is a provider of specialized IT services and solutions, catering to a global clientele primarily in the information technology sector. The company focuses on delivering software development services and embedded platforms, with an emphasis on enhancing the efficiency and cost-effectiveness of IT initiatives. By reducing risk in project execution, Achievo enables its clients to improve profitability and foster business growth.

Beijing Sumavision Co., Ltd. is a prominent Chinese high-tech company specializing in digital television software and systems. It stands out as the only provider of comprehensive digital TV solutions and offers a one-stop service for its clients. Sumavision has maintained the top position in the domestic market for front-end hardware products for seven consecutive years, capturing 50% of the market share in national digital TV translation provinces. Its products are utilized across 43 provinces and regions in China, supporting over 40 national and provincial broadcast systems, as well as more than 700 city and county TV stations. Sumavision's market share in China leads among similar products, while internationally, its offerings have been exported to over 70 countries, with Europe and North America accounting for a significant portion of its overseas trade. The company is engaged in the research, development, and production of a wide range of digital television products, including head-end hardware, encoding and transcoding solutions, and IPTV/OTT systems.

Beijing ACCB Biotech Ltd., established in 2004, specializes in developing and commercializing molecular cancer detection and diagnostic technologies. The company offers a range of products and services, including kits and tests for cancer screening, early detection, prognosis evaluation, personalized cancer therapies, and recurrence monitoring. Its key products are EnzymAct, a non-invasive cancer screening kit, and BiomarkXP, a service platform for prognosis evaluation and therapeutic monitoring. ACCB Biotech's technologies cater to various cancer types, such as esophageal, gastric, colon, and breast cancer, among others. The company operates state-of-the-art facilities, spanning over 3,000 square meters, and adheres to stringent cleanliness standards. ACCB Biotech has a strategic partnership with Beijing Jianxun Fangcheng Software Technology Co. Ltd. and has successfully gained approval for its EnzymAct product from the State Food and Drug Administration.

Beijing Sumavision Co., Ltd. is a prominent Chinese high-tech company specializing in digital television software and systems. It stands out as the only provider of comprehensive digital TV solutions and offers a one-stop service for its clients. Sumavision has maintained the top position in the domestic market for front-end hardware products for seven consecutive years, capturing 50% of the market share in national digital TV translation provinces. Its products are utilized across 43 provinces and regions in China, supporting over 40 national and provincial broadcast systems, as well as more than 700 city and county TV stations. Sumavision's market share in China leads among similar products, while internationally, its offerings have been exported to over 70 countries, with Europe and North America accounting for a significant portion of its overseas trade. The company is engaged in the research, development, and production of a wide range of digital television products, including head-end hardware, encoding and transcoding solutions, and IPTV/OTT systems.

Beijing Sumavision Co., Ltd. is a prominent Chinese high-tech company specializing in digital television software and systems. It stands out as the only provider of comprehensive digital TV solutions and offers a one-stop service for its clients. Sumavision has maintained the top position in the domestic market for front-end hardware products for seven consecutive years, capturing 50% of the market share in national digital TV translation provinces. Its products are utilized across 43 provinces and regions in China, supporting over 40 national and provincial broadcast systems, as well as more than 700 city and county TV stations. Sumavision's market share in China leads among similar products, while internationally, its offerings have been exported to over 70 countries, with Europe and North America accounting for a significant portion of its overseas trade. The company is engaged in the research, development, and production of a wide range of digital television products, including head-end hardware, encoding and transcoding solutions, and IPTV/OTT systems.